HMG 75 IU — Research Overview

Human Menopausal Gonadotropin (HMG) is a gonadotropin preparation containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity. These glycoprotein hormones interact with their respective receptors, follicle-stimulating hormone receptor (FSHR) and luteinizing hormone/choriogonadotropin receptor (LHCGR), both of which belong to the G protein-coupled receptor (GPCR) superfamily. Activation of these receptors initiates Gsα-coupled signaling pathways, resulting in intracellular cAMP generation, protein kinase A (PKA) activation, and downstream signal transduction processes.

Experimental investigations have utilized HMG as a research tool for studying gonadotropin receptor pharmacology, receptor-ligand interactions, GPCR signaling mechanisms, receptor activation kinetics, and comparative analyses of FSHR and LHCGR-mediated pathways. Research applications include gonadotropin signaling studies, receptor characterization, signal transduction investigations, and mechanistic evaluation of glycoprotein hormone receptor biology.

• High Purity – 99% Purity Guaranteed
• Independently Lab Tested
• Research Grade Quality
• For Laboratory Research Use Only

Intended use: This material is supplied for laboratory and in-vitro research only. It is not a drug, food, or cosmetic and is not intended for human or animal consumption.

HMG 75 IU Chemical Properties

HMG 75 IU Research Applications

HMG (Human Menopausal Gonadotropin) is a gonadotropin preparation standardized for both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) bioactivity, typically providing a balanced ratio of FSH and LH activity. The FSH component interacts with follicle-stimulating hormone receptor (FSHR), while the LH component interacts with luteinizing hormone/choriogonadotropin receptor (LHCGR), both members of the G protein-coupled receptor (GPCR) superfamily. Activation of these receptors initiates Gsα-coupled signaling pathways, resulting in intracellular cAMP generation, protein kinase A (PKA) activation, and downstream signal transduction processes associated with gonadotropin receptor signaling. As a biologically sourced glycoprotein preparation, HMG contains multiple glycoforms exhibiting varying degrees of glycosylation and sialylation. This molecular heterogeneity distinguishes HMG from recombinant single-hormone preparations and has made it a useful research tool for investigating glycoprotein hormone structure-function relationships, receptor-ligand interactions, receptor activation kinetics, and the influence of glycosylation patterns on GPCR signaling dynamics. Research applications include gonadotropin receptor pharmacology, FSHR and LHCGR signaling studies, glycoprotein hormone characterization, and mechanistic evaluation of receptor-mediated signal transduction. HMG 75 IU per vial. Independently third-party HPLC-tested; COA available per batch.

HMG 75 IU Lab Results & Certificates of Analysis

Third-party analytical reports associated with this research compound:

• HMG (HPLC) — June 24, 2026 | Verification
• HMG (HPLC) — June 24, 2026 | Verification
• HMG (HPLC) — June 24, 2026 | Verification

HMG 75 IU Frequently Asked Questions

Research Use Disclaimer

All product information is provided for educational and laboratory research reference only. Any form of introduction into humans or animals is prohibited. Handle only in licensed research settings in accordance with applicable laws and institutional protocols.